Results 31 to 40 of about 1,739,773 (346)

The efficacy and safety of uniportal video-assisted thoracic surgery on the treatment for stage II-III tuberculous empyema: a single-arm clinical retrospective study from 2016 to 2021 in a thoracic surgery center in China

BMC Pulmonary Medicine, 2022
Background Surgery is an important adjuvant treatment for tuberculous empyema(TE). We thus conducted a single arm-clinical retrospective study of stage II-III TE patients who underwent uniportal video-assisted thoracic surgery (Uni-VATS) over a 5-year ...
Wenwen Sun, Guidong Yin, Haomin Cai, Yiming Zhou, Jin Gu, Shanhao Chen, Lin Fan   +6 more
doaj   +1 more source

Clinical Features of Nontuberculous Mycobacterial Pulmonary Disease in the Yangtze River Delta of China: A Single-Center, Retrospective, Observational Study

Tropical Medicine and Infectious Disease, 2023
With increased focus on nontuberculous mycobacterial pulmonary disease (NTM-PD), and the improvement in detection methods, the global incidence continues to increase every year, but the diagnosis and treatment are difficult with a high misdiagnosis rate ...
Hai Lou, Ansheng Zou, Xiaona Shen, Yong Fang, Qin Sun, Fen Zhang, Wei Sha   +6 more
doaj   +1 more source

Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses. [PDF]

, 2019
BackgroundClinical tuberculosis diagnosis and empiric treatment have traditionally been common among patients with negative bacteriologic test results. Increasing availability of rapid molecular diagnostic tests, including Xpert MTB/RIF and the new Xpert
Cattamanchi, Adithya, Dowdy, David W, Isooba, David, Kamoga, Caleb, Katamba, Achilles, Kato-Maeda, Midori, Kendall, Emily A, Kitonsa, Peter J, Mukiibi, James, Nakasolya, Olga, Nalutaaya, Annet, Robsky, Katherine, Salvatore, Phillip P   +12 more
core   +2 more sources

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults

Cochrane Database of Systematic Reviews, 2019
Background Xpert MTB/RIF (Xpert MTB/RIF) and Xpert MTB/RIF Ultra (Xpert Ultra), the newest version, are the only World Health Organization (WHO)‐recommended rapid tests that simultaneously detect tuberculosis and rifampicin resistance in persons with ...
D. Horne, Mikashmi Kohli, Jerry S Zifodya, Ian Schiller, N. Dendukuri, D. Tollefson, S. Schumacher, E. Ochodo, M. Pai, K. Steingart   +9 more
semanticscholar   +1 more source

Factors Influencing False-Negative Results of QuantiFERON-TB Gold In-Tube (QFT-GIT) in Active Tuberculosis and the Desirability of Resetting Cutoffs for Different Populations: A Retrospective Study

Tropical Medicine and Infectious Disease, 2022
Objectives The value of QuantiFERON-TB Gold In-Tube (QFT-GIT) in the diagnosis of TB varies by population, comorbidities, and other factors. In this study, we aimed to investigate factors that influence false-negative results of QFT-GIT test in the ...
Yuanyuan Yu, Yidian Liu, Lan Yao, Yanheng Shen, Qin Sun, Wei Sha   +5 more
doaj   +1 more source

Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation

European Respiratory Journal, 2019
Chronic pulmonary aspergillosis (CPA) complicates treated pulmonary tuberculosis (TB), with high 5-year mortality. We measured CPA prevalence in this group.
I. Page, R. Byanyima, S. Hosmane, Nathan Onyachi, C. Opira, M. Richardson, R. Sawyer, A. Sharman, D. Denning   +8 more
semanticscholar   +1 more source

Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities [PDF]

, 2012
Tuberculosis is unique among the major infectious diseases in that it lacks accurate rapid point-of-care diagnostic tests. Failure to control the spread of tuberculosis is largely due to our inability to detect and treat all infectious cases of pulmonary
Alexandre Harari, Alimuddin Zumla, Armand, Axelsson-Robertson, Banada, Ben Marais, Betsou, Blakemore, Boehme, Boehme, Cattamanchi, Chow, Cuevas, Cuevas, Cuevas, Cuevas, Diel, Dowdy, Dye, European Centre for Disease Prevention and Control, Ferrara, Giovanni-Batista Migliori, Giuseppe Pantaleo, Green, Harari, Helb, Helen Cox, Hillemann, Hohn, Ibrahim Abubakar, Jeremiah Chakaya, John, Justin O’Grady, Karin Weyer, Keeler, Kemp, Kunnath-Velayudhan, Lawn, Lawn, Lawn, Lawn, Lawn, Lemaire, Lin, Ling, Liu, Long, Lucica Ditui, Lynn Zijenah, Mann, Marais, Marais, Marais, Marais, Marco Schito, Markus Maeurer, Marlowe, Martin P. Grobusch, Martina Casenghi, Matthew Bates, McNerney, Michael Hoelscher, Michel Pletschette, Minion, Moore, Morris, Mwaba, Nathan Ford, Nathanson, National Institute for Health and Clinical Excellence, Nicol, Nicol, Oberhelman, O’Grady, Peter, Peter Mwaba, Peter S. Kim, Rifat Atun, Rose, Ruth McNerney, S. Bertel Squire, Samana Schwank, Sester, Shah, Soumya Swaminathan, Squire, Squire, Steingart, Steingart, Steingart, Steve Lawn, Storla, Temple, Theron, Timothy D. Mchugh, Treatment Action Group, Tully, Vadwai, Van Rie, van Wyk, Wallis, Walzl, Weyer, Wilson, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, World Health Organization, Wright, Wright, Zar, Ziad Memish, Zumla, Zumla   +118 more
core   +2 more sources

Psychosocial Need Analysis of Patients with Pulmonary Tuberculosis. [PDF]

, 2014
Pulmonary tuberculosis (TB) is a chronic pulmonary disease impacted on physical and psychosocial of the patients. However, to date, the goverment’s programs has not address the psychososial problem of the patients yet.
Hernawati, T. (Taty), Sriati, A. (Aat), Suryani, S. (Suryani), Widianti, E. (Efri)   +3 more
core   +2 more sources

Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers

PLoS ONE, 2013
Rationale New approaches to define factors underlying the immunopathogenesis of pulmonary diseases including sarcoidosis and tuberculosis are needed to develop new treatments and biomarkers. Comparing the blood transcriptional response of tuberculosis to
C. Bloom, C. Graham, M. Berry, Fotini Rozakeas, Paul S. Redford, Yuanyuan Wang, Zhaohui Xu, K. Wilkinson, R. Wilkinson, Y. Kendrick, G. Devouassoux, T. Ferry, M. Miyara, D. Bouvry, Valeyre Dominique, G. Gorochov, D. Blankenship, M. Saadatian, P. Vanhems, H. Beynon, R. Vancheeswaran, M. Wickremasinghe, D. Chaussabel, J. Banchereau, V. Pascual, L. Ho, M. Lipman, A. O’Garra   +27 more
semanticscholar   +1 more source

The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients

Frontiers in Cellular and Infection Microbiology, 2019
Cross talk occurs between the human gut and the lung through a gut-lung axis involving the gut microbiota. However, the signatures of the human gut microbiota after active Mycobacterium tuberculosis infection have not been fully understood.
Yongfei Hu, Yuqing Feng, Jiannan Wu, Fei Liu, Zhiguo Zhang, Yanan Hao, S. Liang, Boxing Li, Jing Li, Na Lv, Yuhui Xu, B. Zhu, Zhaogang Sun   +12 more
semanticscholar   +1 more source